Home › NDC Lookup › Drug shortages › Omeprazole Delayed Release Capsule

Omeprazole Delayed Release Capsule shortage

Omeprazole Delayed Release Capsule is currently listed in shortage by the FDA. The FDA lists 10 affected products. This page was last refreshed from FDA data on Oct 2, 2026.

To Be Discontinued ⚠ Supply risk: High Gastroenterology 10 products 359 days First posted Oct 9, 2025 Updated Oct 9, 2025
Here’s the bottom line

Sandoz is permanently stopping its omeprazole delayed-release capsules (10 mg, 20 mg, and 40 mg). Other manufacturers — including Major Pharmaceuticals and NorthStar Rx — still list the same strengths as available.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
10
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/3
Affected strengths supplied
359
Days in shortage
125,474
Medicaid Rx (2026)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 2, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Omeprazole Delayed Release Capsule. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
10 NDCs
To be discontinued 10
Affected strengths still supplied
Among manufacturers reporting this shortage
0/3 strengths
No supply 3
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Omeprazole Delayed Release Capsule from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Sandoz Inc Major Pharmaceuticals NorthStar Rx LLC PD-Rx Pharmaceuticals, Inc. Aphena Pharma Solutions - Tennessee, LLC Quality Care Products, LLC A-S Medication Solutions AvPAK
Plus 13 alternative dosage forms of Omeprazole Delayed Release Capsule.
See all other options & details →
Shortage timeline
  1. Oct 9, 2025
    Currently in shortage
    10 of 10 products affected.
  2. Oct 9, 2025
    First reported to the FDA
    10 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Sandoz Inc. 📞 800-525-8747 10 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-01) NDC 00781-2859-01 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-01) NDC 00781-2868-01 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-31) NDC 00781-2859-31 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-10) NDC 00781-2234-10 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-31) NDC 00781-2234-31 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-10) NDC 00781-2859-10 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-01) NDC 00781-2234-01 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-31) NDC 00781-2868-31 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-10) NDC 00781-2868-10 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-92) NDC 00781-2868-92 — — Discontinuation of the manufacture of the drug —

These rows are manufacturer reports to the FDA for Omeprazole Delayed Release Capsule — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Omeprazole Delayed Release Capsule? options further down this page.

Why is Omeprazole Delayed Release Capsule in shortage?

Sandoz has reported to the FDA that they are permanently stopping the manufacturing of their omeprazole delayed-release capsules across all three strengths — the 10 mg, 20 mg, and 40 mg capsules. This is a full discontinuation from Sandoz, meaning they don't plan to bring these products back. No specific reason was shared publicly as to why they made this business decision.

It's worth knowing that this report only covers Sandoz's versions of omeprazole. Other manufacturers may produce their own versions of this medication and are listed separately on the FDA's shortage page.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Omeprazole Delayed Release Capsule, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Omeprazole Delayed Release Capsule?

Omeprazole Delayed Release Capsules are currently on the FDA shortage list. I know that can feel unsettling when it's a medicine you count on, so let me walk you through what this report actually says.

All three strengths covered by this record — 10 mg, 20 mg, and 40 mg — are listed with no available source right now. This shortage reflects a single manufacturer, Sandoz Inc., which has reported it is discontinuing production of these capsules. Because the status is "to be discontinued," this supply change from Sandoz may be permanent. That does not mean the medicine is gone from the market — other companies make the very same omeprazole delayed-release capsule, and they are not part of this discontinuation.

Here's what I'd suggest, in order:

  • Do not stop, skip, or change your dose on your own.
  • Ask your pharmacy to source the same medicine from another maker. The same omeprazole delayed-release capsule is listed from makers such as Major Pharmaceuticals, NorthStar Rx, and others — though it may not be on your local shelf and may need to be ordered.
  • If your exact strength can't be found, ask your prescriber or pharmacist about options, such as a different strength to reach your dose or a clinician-chosen alternative.

Manufacturer contact numbers are listed on this page for reference, though your pharmacy usually handles those calls. This is national, manufacturer-reported data and may not match your local pharmacy's actual stock.

See “Where else can I get Omeprazole Delayed Release Capsule?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Omeprazole guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Omeprazole guide →

Where else can I get Omeprazole Delayed Release Capsule?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Omeprazole Delayed Release Capsule is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Omeprazole OMEPRAZOLE 10 mg/1 Capsule, Delayed Release · Oral Sandoz Inc 00781-2785-01
Omeprazole OMEPRAZOLE 20 mg/1 Capsule, Delayed Release · Oral Sandoz Inc 00781-2790-01
Omeprazole OMEPRAZOLE 20 mg/1 Capsule, Delayed Release · Oral Major Pharmaceuticals 00904-6917-61
Omeprazole OMEPRAZOLE 40 mg/1 Capsule, Delayed Release · Oral NorthStar Rx LLC 16714-0123-01
Omeprazole OMEPRAZOLE 10 mg/1 Capsule, Delayed Release · Oral NorthStar Rx LLC 16714-0630-01
Omeprazole OMEPRAZOLE 20 mg/1 Capsule, Delayed Release · Oral NorthStar Rx LLC 16714-0634-01
Omeprazole OMEPRAZOLE 20 mg/1 Capsule, Delayed Release · Oral PD-Rx Pharmaceuticals, Inc. 43063-0743-14
Omeprazole OMEPRAZOLE 40 mg/1 Capsule, Delayed Release · Oral Aphena Pharma Solutions - Tennessee, LLC 43353-0829-60
Omeprazole OMEPRAZOLE 20 mg/1 Capsule, Delayed Release · Oral Quality Care Products, LLC 49999-0265-14
Omeprazole OMEPRAZOLE 20 mg/1 Capsule, Delayed Release · Oral A-S Medication Solutions 50090-1157-00
Omeprazole OMEPRAZOLE 40 mg/1 Capsule, Delayed Release · Oral A-S Medication Solutions 50090-2769-00
Omeprazole OMEPRAZOLE 40 mg/1 Capsule, Delayed Release · Oral AvPAK 50268-0657-15

Alternative dosage forms of Omeprazole Delayed Release Capsule

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 30 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Omeprazole 20 mgNDC 16714-0715-01 NorthStar 30 capsules $0.028 save 3% AB Discontinued
Omeprazole 20 mgNDC 60505-0065-00 Apotex 30 capsules $0.028 save 3% AB Discontinued
Omeprazole 20 mgNDC 68084-0128-01 American 1 capsule $0.028 save 3% AB Discontinued
Omeprazole 20 mgNDC 00781-2868-01 Sandoz 100 capsules $0.029 AB Availability likely
Omeprazole 20 mgNDC 00904-6917-61 Major 1 capsule $0.029 +3% AB Availability likely
Omeprazole 20 mgNDC 16714-0634-01 NorthStar 30 capsules $0.029 +3% AB Availability likely
Omeprazole 20 mgNDC 55111-0158-01 Dr. 100 capsules $0.029 +3% — Availability likely
Omeprazole 20 mgNDC 55111-0644-01 Dr. 100 capsules $0.029 +3% AB Availability likely
Omeprazole 20 mgNDC 60687-0597-01 American 1 capsule $0.029 +3% AB Availability likely
Omeprazole 20 mgNDC 68382-0412-01 Zydus 100 capsules $0.029 +3% AB Availability likely
Omeprazole 20 mgNDC 68462-0396-01 Glenmark 100 capsules $0.029 +3% AB Availability likely
Omeprazole 20 mgNDC 82009-0022-10 Quallent 1000 capsules $0.029 +3% AB Availability likely
Omeprazole 20 mgNDC 82009-0183-10 Quallent 1000 capsules $0.029 +3% AB Availability likely
Omeprazole 20 mgNDC 60505-3952-03 Apotex 30 capsules $0.034 +20% AB Discontinued
Omeprazole 20 mgNDC 62175-0118-32 Lannett 30 capsules $0.036 +26% AB FDA listed
Omeprazole 10 mgNDC 16714-0630-01 NorthStar 30 capsules $0.077 save 6% AB Availability likely
Omeprazole 10 mgNDC 16714-0714-01 NorthStar 30 capsules $0.077 save 6% AB Availability likely
Omeprazole 10 mgNDC 55111-0157-01 Dr. 100 capsules $0.077 save 6% AB Availability likely
Omeprazole 10 mgNDC 55111-0643-01 Dr. 100 capsules $0.077 save 6% AB Availability likely
Omeprazole 10 mgNDC 59651-0001-01 Aurobindo 100 capsules $0.077 save 6% — Availability likely
Omeprazole 10 mgNDC 62135-0559-30 Chartwell 30 capsules $0.077 save 6% AB Availability likely
Omeprazole 10 mgNDC 68382-0411-01 Zydus 100 capsules $0.077 save 6% AB Availability likely
Omeprazole 10 mgNDC 68462-0395-01 Glenmark 100 capsules $0.077 save 6% AB Availability likely
Omeprazole 10 mgNDC 00781-2859-01 Sandoz 100 capsules $0.082 AB Availability likely
Omeprazole 10 mgNDC 60505-0145-00 Apotex 30 capsules $0.082 AB Discontinued
Omeprazole 10 mgNDC 62135-0530-30 Chartwell 30 capsules $0.082 AB Availability likely
Omeprazole 10 mgNDC 00781-2859-31 Sandoz 30 capsules $0.082 AB Availability likely
Omeprazole 10 mgNDC 62175-0114-32 Lannett 30 capsules $0.090 +11% AB FDA listed
Omeprazole Magnesium 20 mgNDC 55111-0397-27 Dr. 14 capsules $0.395 +1282% — Availability likely
Acid Reducer 20 mgNDC 70000-0232-01 LEADER/ 14 capsules $0.395 +1282% — Availability likely

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Omeprazole Delayed Release Capsule — that fall in the same broad treatment class (proton-pump inhibitors) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 043136
GCN 92989
HICL code 004673
Ingredient (HICL) Omeprazole
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4J
Therapeutic class — specific (HIC3) Proton-Pump Inhibitors
AHFS code 56:28.36.00
AHFS class Proton-Pump Inhibitors
FDB label name OMEPRAZOLE DR 10 MG CAPSULE
FDB brand name Omeprazole
Legend status F — Federal legend — prescription drug or device
GPI-1449270060006510
GPI classOmeprazole
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other gastroenterology shortages

Omeprazole Delayed Release Capsule shortage FAQs

Is Omeprazole Delayed Release Capsule in shortage?
Yes — the FDA currently lists Omeprazole Delayed Release Capsule in shortage (status: “To Be Discontinued”, first reported Oct 9, 2025). 10 of 10 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-01) (NDC 00781-2859-01); Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-01) (NDC 00781-2868-01); Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-31) (NDC 00781-2859-31). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Omeprazole Delayed Release Capsule be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Omeprazole Delayed Release Capsule somewhere?
Other manufacturers (Sandoz Inc, Major Pharmaceuticals, NorthStar Rx LLC and others) still market it and have not reported a shortage. 13 alternative dosage forms of Omeprazole Delayed Release Capsule are also listed. See “Where else can I get Omeprazole Delayed Release Capsule?” above — stock still varies by pharmacy.
What should I do if I take Omeprazole Delayed Release Capsule?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Omeprazole Delayed Release Capsule shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages